Request Demo
Last update 22 Nov 2025
HRS-8807
Last update 22 Nov 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms HRS 8807, HRS8807 |
Target |
Action inhibitors |
Mechanism Ca2+-ATPases inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with HRS-8807NCT04993430
A Phase 1, Single Arm, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability and Pharmacokinetic of HRS8807 Monotherapy and in Combination With SHR6390 in Subjects With ER-Positive, HER2-Negative Metastatic or Locally Advanced Breast Cancer
CTR20211746
HRS8807单药及联合SHR6390在ER阳性、HER2阴性转移性或局部晚期乳腺癌患者中的安全性、耐受性及药代动力学的单臂、开放、多中心I期临床研究
[Translation] A single-arm, open-label, multicenter phase I clinical study on the safety, tolerability and pharmacokinetics of HRS8807 alone and in combination with SHR6390 in patients with ER-positive, HER2-negative metastatic or locally advanced breast cancer
100 Clinical Results associated with HRS-8807
Login to view more data
100 Translational Medicine associated with HRS-8807
Login to view more data
100 Patents (Medical) associated with HRS-8807
Login to view more data
100 Deals associated with HRS-8807
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced breast cancer | Phase 1 | China | 26 Oct 2021 | |
| ER-positive/HER2-negative Breast Cancer | Phase 1 | China | 26 Oct 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | ER-positive/HER2-negative Breast Cancer ER positive | HER2 negative | 7 | fjbeyjbzxt(efunuibgla) = xgwszikwhm ctwflgyxrd (jlnmjiguto ) View more | Positive | 23 Oct 2023 | ||
(150 mg) | fdcgivinkz(crwsglozku) = xoxvukrbdt pmnwxysize (qylrttthdl, 9.4 - 99.2) |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free